Cargando…
Can Aminoglycosides Be Used as a New Treatment for Helicobacter pylori? In vitro Activity of Recently Isolated Helicobacter pylori
BACKGROUND: Smectite can serve as a drug delivery system and gentamicin-intercalated smectite hybrids are expected to supersede the standard therapy for Helicobacter pylori eradication. The aim of this study was to confirm whether the minimum inhibitory concentration (MIC) of aminoglycosides applied...
Autores principales: | Lee, Kyoung Hwa, Park, Soon Young, Jeong, Su Jin, Jung, Da Hyun, Kim, Jie-Hyun, Jeong, Seok Hoon, Kang, Il-Mo, Song, Young Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446016/ https://www.ncbi.nlm.nih.gov/pubmed/30941933 http://dx.doi.org/10.3947/ic.2019.51.1.10 |
Ejemplares similares
-
2449. Validation of In Vitro Activity of Aminoglycosides Against Recently Isolated Helicobacter pylori for Commercialization of Gentamicin-Intercalated Smectite Hybrid as a New Therapeutic Agent
por: Lee, Kyoung Hwa, et al.
Publicado: (2018) -
Peptide Nucleic Acid Probe-Based Analysis as a New Detection Method for Clarithromycin Resistance in Helicobacter pylori
por: Jung, Da Hyun, et al.
Publicado: (2018) -
Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020) -
Novel Mutations Conferring Amoxicillin Resistance in Helicobacter pylori in South Korea
por: Park, Soon Young, et al.
Publicado: (2023) -
Efficacy and Gut Dysbiosis of Gentamicin-Intercalated Smectite as a New Therapeutic Agent against Helicobacter pylori in a Mouse Model
por: Jeong, Su Jin, et al.
Publicado: (2020)